Millipore Sigma Vibrant Logo

520219 PPACK II, Trifluoroacetate Salt - CAS 74392-49-7 - Calbiochem

View This Product on Sigma-Aldrich
520219
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
74392-49-7C₂₅H₃₃ClN₆O₃ . 2CF₃COOH

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
520219-10MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewPotent and specific irreversible inhibitor of plasma and glandular kallikreins. Also available as a 10 mM solution in H2O (Cat. No. 508573).
      Catalogue Number520219
      Brand Family Calbiochem®
      References
      ReferencesByrne, R.E., and Scanu, A.M. 1989. J. Lipid Res. 30, 109.
      Scicli, G., et al. 1989. Adv. Exp. Med. Biol. 247B, 217.
      Gibson, T.R., et al. 1987. Endocrinology 120, 764.
      Kettner, G., and Shaw, E. 1981. Methods Enzymol. 80, 826.
      Product Information
      CAS number74392-49-7
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₂₅H₃₃ClN₆O₃ . 2CF₃COOH
      Chemical formulaC₂₅H₃₃ClN₆O₃ . 2CF₃COOH
      ReversibleN
      Quality LevelMQ100
      Applications
      ApplicationPPACK II, Trifluoroacetate Salt, CAS 74392-49-7, is a potent, specific, and irreversible inhibitor of plasma and glandular kallikreins.
      Biological Information
      Primary TargetPlasma and glandular kallikreins
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Peptide SequenceH-D-Phe-Phe-Arg-chloromethylketone, 2TFA
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      520219-10MGCN 04055977271928

      Documentation

      PPACK II, Trifluoroacetate Salt - CAS 74392-49-7 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      PPACK II, Trifluoroacetate Salt - CAS 74392-49-7 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      520219

      参考資料

      参考資料の概要
      Byrne, R.E., and Scanu, A.M. 1989. J. Lipid Res. 30, 109.
      Scicli, G., et al. 1989. Adv. Exp. Med. Biol. 247B, 217.
      Gibson, T.R., et al. 1987. Endocrinology 120, 764.
      Kettner, G., and Shaw, E. 1981. Methods Enzymol. 80, 826.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-October-2013 JSW
      DescriptionPotent and specific irreversible inhibitor of plasma and glandular kallikreins. Inhibits the cleavage of atrial naturiuretic peptide (ANP 1-126) by kallikreins. Also inhibits adrenal kininogenase, a kallikrein-like enzyme.
      FormOff-white solid
      CAS number74392-49-7
      Chemical formulaC₂₅H₃₃ClN₆O₃ . 2CF₃COOH
      Peptide SequenceH-D-Phe-Phe-Arg-chloromethylketone, 2TFA
      Purity≥95% by HPLC
      SolubilityH₂O (100 mg/ml)
      Storage Protect from moisture
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
      Toxicity Standard Handling
      ReferencesByrne, R.E., and Scanu, A.M. 1989. J. Lipid Res. 30, 109.
      Scicli, G., et al. 1989. Adv. Exp. Med. Biol. 247B, 217.
      Gibson, T.R., et al. 1987. Endocrinology 120, 764.
      Kettner, G., and Shaw, E. 1981. Methods Enzymol. 80, 826.